down arrow

Artemis Medicare

  • Market Cap: Small Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE025R01021
  • NSEID: ARTEMISMED
  • BSEID: 542919
INR
286.00
9.6 (3.47%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 41.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
878.57
737.43
554.80
408.40
565.02
546.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
878.57
737.43
554.80
408.40
565.02
546.52
Raw Material Cost
0.00
0.00
0.00
114.89
141.24
129.41
Purchase of Finished goods
0.00
0.00
0.10
0.30
1.49
1.45
(Increase) / Decrease In Stocks
0.00
0.00
0.13
1.27
-3.84
-0.28
Employee Cost
138.95
120.78
104.30
83.99
103.42
97.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
540.31
459.93
341.54
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
66.61
62.77
41.28
172.76
261.25
254.85
Total Expenditure (Excl Depreciation)
745.87
643.48
487.35
373.21
503.56
482.71
Operating Profit (PBDIT) excl Other Income
132.70
93.95
67.45
35.19
61.46
63.81
Other Income
7.35
7.34
3.90
3.54
4.60
4.00
Operating Profit (PBDIT)
140.05
101.29
71.35
38.73
66.06
67.81
Interest
31.29
19.68
11.98
12.93
12.80
11.00
Exceptional Items
0.00
0.00
0.00
3.23
0.00
0.00
Gross Profit (PBDT)
108.76
81.61
59.37
29.03
53.26
56.81
Depreciation
40.32
31.00
22.19
21.51
22.63
20.07
Profit Before Tax
68.45
50.61
37.18
7.53
30.63
36.74
Tax
19.31
12.59
5.78
1.37
11.17
16.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
49.14
38.01
31.40
6.16
19.46
20.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
49.14
38.01
31.40
6.16
19.46
20.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.59
0.41
0.33
0.33
0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
49.14
38.60
31.81
6.49
19.79
20.49
Equity Capital
13.59
13.41
13.24
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
10.0
10.0
10.0
Reserves
366.78
0.00
279.26
240.57
234.02
214.55
Earnings per share (EPS)
3.62
2.88
2.4
4.9
14.95
15.48
Diluted Earnings per share
3.53
2.79
2.29
4.9
14.95
15.48
Operating Profit Margin (Excl OI)
15.1%
12.74%
12.16%
8.62%
10.88%
11.68%
Gross Profit Margin
12.38%
11.07%
10.7%
7.11%
9.43%
10.39%
PAT Margin
5.59%
5.15%
5.66%
1.51%
3.44%
3.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 19.14% vs 32.92% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 27.31% vs 21.35% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 41.25% vs 39.29% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 58.99% vs 64.27% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Artemis Medicare With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
878.57
3,275.11
-2,396.54
-73.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
878.57
3,275.11
-2,396.54
-73.17%
Raw Material Cost
0.00
687.69
-687.69
-100.00%
Purchase of Finished goods
0.00
73.97
-73.97
-100.00%
(Increase) / Decrease In Stocks
0.00
-2.29
2.29
100.00%
Employee Cost
138.95
734.86
-595.91
-81.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
540.31
-0.01
540.32
5,403,200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
66.61
981.81
-915.20
-93.22%
Total Expenditure (Excl Depreciation)
745.87
2,476.03
-1,730.16
-69.88%
Operating Profit (PBDIT) excl Other Income
132.70
799.08
-666.38
-83.39%
Other Income
7.35
74.66
-67.31
-90.16%
Operating Profit (PBDIT)
140.05
873.74
-733.69
-83.97%
Interest
31.29
73.91
-42.62
-57.66%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
108.76
799.83
-691.07
-86.40%
Depreciation
40.32
172.73
-132.41
-76.66%
Profit Before Tax
68.45
627.10
-558.65
-89.08%
Tax
19.31
149.04
-129.73
-87.04%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
49.14
478.06
-428.92
-89.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
49.14
478.06
-428.92
-89.72%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.13
-0.13
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
49.14
478.19
-429.05
-89.72%
Equity Capital
13.59
53.70
-40.11
-74.69%
Face Value
1.00
2.00
0.00
Reserves
366.78
2,851.93
-2,485.15
-87.14%
Earnings per share (EPS)
3.62
17.81
-14.19
-79.67%
Diluted Earnings per share
3.53
17.80
-14.27
-80.17%
Operating Profit Margin (Excl OI)
15.10%
24.40%
0.00
-9.30%
Gross Profit Margin
12.38%
24.42%
0.00
-12.04%
PAT Margin
5.59%
14.60%
0.00
-9.01%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 878.57 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.14% vs 32.92% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 49.14 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 27.31% vs 21.35% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.70 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 41.25% vs 39.29% in Mar 2023

Annual - Interest
Interest 31.29 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 58.99% vs 64.27% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.10%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023